227 related articles for article (PubMed ID: 25081280)
21. The value of a rate change in determining the tachycardia mechanism: what is the mechanism?
Sternick EB; Correa FS; Lokhandwala Y; Wellens HJJ
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):913-915. PubMed ID: 24678872
[No Abstract] [Full Text] [Related]
22. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
23. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
Tanno K; Kobayashi Y; Miyata A; Chiyoda K; Nakagawa H; Kurano K; Kikushima S; Yazawa T; Baba T; Mukai H
Kokyu To Junkan; 1992 Sep; 40(9):897-902. PubMed ID: 1439290
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiographic and electrophysiologic effects of dexmedetomidine on children.
Ergul Y; Unsal S; Ozyilmaz I; Ozturk E; Carus H; Guzeltas A
Pacing Clin Electrophysiol; 2015 Jun; 38(6):682-7. PubMed ID: 25753681
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological study generally is negative in patients <40 years suspected of supraventricular tachycardia but also complaining of chest pain and/or syncope.
Brembilla-Perrot B; Sellal JM; Olivier A; Villemin T; Manenti V; Brembilla A; Rizk J; Chillou CD; Moulin-Zinsch A; Marçon F; Girerd N
Int J Cardiol; 2016 Jan; 203():1109-13. PubMed ID: 26646383
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical effect of isoprenaline infusion.
Brembilla-Perrot B; Muhanna I; Nippert M; Popovic B; Beurrier D; Houriez P; Terrier de la Chaise A; Claudon O; Louis P; Abdelaal A; State S; Andronache M; Suty-Selton C
Europace; 2005 Nov; 7(6):621-7. PubMed ID: 16216767
[TBL] [Abstract][Full Text] [Related]
27. The effects of dexmedetomidine on cardiac electrophysiology in children.
Hammer GB; Drover DR; Cao H; Jackson E; Williams GD; Ramamoorthy C; Van Hare GF; Niksch A; Dubin AM
Anesth Analg; 2008 Jan; 106(1):79-83, table of contents. PubMed ID: 18165557
[TBL] [Abstract][Full Text] [Related]
28. Supraventricular tachycardia: what is the mechanism?
Miyazaki S; Taniguchi H; Koura K; Uchiyama T; Takayama K; Kusa S; Iesaka Y
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1144-5. PubMed ID: 22269067
[No Abstract] [Full Text] [Related]
29. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
Chiou CW; Chen SA; Kung MH; Chang MS; Prystowsky EN
Circulation; 2003 May; 107(20):2583-8. PubMed ID: 12743004
[TBL] [Abstract][Full Text] [Related]
30. Hisian response to atrial pacing during tachycardia: understanding the physiology behind the rules.
Roshan J; Nanthakumar K; Nair K; Chauhan VS
J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1308-10. PubMed ID: 23844905
[No Abstract] [Full Text] [Related]
31. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
[TBL] [Abstract][Full Text] [Related]
32. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
[TBL] [Abstract][Full Text] [Related]
33. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway].
Fassini G; Riva S; Della Bella P; Carbucicchio C; Tondo C
Cardiologia; 1996 Sep; 41(9):869-75. PubMed ID: 8983843
[TBL] [Abstract][Full Text] [Related]
35. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of ablative therapy of postoperative supraventricular tachycardias in patients with univentricular heart: a European multicenter study.
de Groot NM; Lukac P; Blom NA; van Kuijk JP; Pedersen AK; Hansen PS; Delacretaz E; Schalij MJ
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):242-8. PubMed ID: 19808474
[TBL] [Abstract][Full Text] [Related]
37. A technique for diagnosis of accessory pathway using the H-H and A-A intervals of the first entrained cycle during ventricular overdrive pacing.
Matsushita T; Ishida S; Oketani N; Ichiki H; Ninomiya Y; Hamasaki S; Tei C
Am J Cardiol; 2008 Jul; 102(2):197-202. PubMed ID: 18602521
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of repolarization change during initiation of supraventricular tachycardia.
Lin YJ; Tai CT; Chiang CE; Lee KT; Yuniadi Y; Huang BH; Liu TY; Lee PC; Kuo JY; Chen SA
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1233-7. PubMed ID: 15574169
[TBL] [Abstract][Full Text] [Related]
39. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
40. Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy.
Zacks ES; Morin DP; Ageno S; Janik M; Mauer AC; Markowitz SM; Mittal S; Iwai S; Shah BK; Lerman BB; Stein KM
Am Heart J; 2007 Mar; 153(3):392-7. PubMed ID: 17307418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
